Search

Anna Pagonakis

Examiner (ID: 6985)

Most Active Art Unit
1628
Art Unit(s)
1614, 4173, 1609, 1628, OPET
Total Applications
1238
Issued Applications
444
Pending Applications
73
Abandoned Applications
723

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5051893 [patent_doc_number] => 20070032438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/194676 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3981 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032438.pdf [firstpage_image] =>[orig_patent_app_number] => 11194676 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/194676
Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions Aug 1, 2005 Abandoned
Array ( [id] => 6931858 [patent_doc_number] => 20050282893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Methods and compositions for using suramin, pentosan, polysulfate, telomerase antisense and telomerase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/193883 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22535 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282893.pdf [firstpage_image] =>[orig_patent_app_number] => 11193883 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/193883
Methods and compositions for using suramin, pentosan, polysulfate, telomerase antisense and telomerase inhibitors Jul 28, 2005 Abandoned
Array ( [id] => 5820047 [patent_doc_number] => 20060024360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof' [patent_app_type] => utility [patent_app_number] => 11/192439 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11479 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024360.pdf [firstpage_image] =>[orig_patent_app_number] => 11192439 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/192439
Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof Jul 27, 2005 Abandoned
Array ( [id] => 4872691 [patent_doc_number] => 20080199425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Sensitization of Immune System Against Haptenized Melanoma Antigens' [patent_app_type] => utility [patent_app_number] => 11/996753 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7785 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199425.pdf [firstpage_image] =>[orig_patent_app_number] => 11996753 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/996753
Sensitization of Immune System Against Haptenized Melanoma Antigens Jul 27, 2005 Abandoned
Array ( [id] => 5415828 [patent_doc_number] => 20090041715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Epothilone Combinations' [patent_app_type] => utility [patent_app_number] => 11/658357 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9052 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041715.pdf [firstpage_image] =>[orig_patent_app_number] => 11658357 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658357
Epothilone Combinations Jul 24, 2005 Abandoned
Array ( [id] => 5074764 [patent_doc_number] => 20070014739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Compositions and methods for controlling biofilms and bacterial infections' [patent_app_type] => utility [patent_app_number] => 11/181556 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21362 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014739.pdf [firstpage_image] =>[orig_patent_app_number] => 11181556 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/181556
Compositions and methods for controlling biofilms and bacterial infections Jul 13, 2005 Abandoned
Array ( [id] => 5769219 [patent_doc_number] => 20060019941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Analogs of benzoquinone-containing ansamycins and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/180314 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38314 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019941.pdf [firstpage_image] =>[orig_patent_app_number] => 11180314 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/180314
Analogs of benzoquinone-containing ansamycins and methods of use thereof Jul 12, 2005 Abandoned
Array ( [id] => 5010439 [patent_doc_number] => 20070280918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Multitherapy Against Cancer' [patent_app_type] => utility [patent_app_number] => 11/572068 [patent_app_country] => US [patent_app_date] => 2005-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7609 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20070280918.pdf [firstpage_image] =>[orig_patent_app_number] => 11572068 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/572068
Multitherapy Against Cancer Jul 11, 2005 Abandoned
Array ( [id] => 6930832 [patent_doc_number] => 20050281867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Nitric oxide inducing agents' [patent_app_type] => utility [patent_app_number] => 11/177761 [patent_app_country] => US [patent_app_date] => 2005-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5900 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281867.pdf [firstpage_image] =>[orig_patent_app_number] => 11177761 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/177761
Nitric oxide inducing agents Jul 7, 2005 Abandoned
Array ( [id] => 5739077 [patent_doc_number] => 20060009468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Method for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/176852 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8055 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009468.pdf [firstpage_image] =>[orig_patent_app_number] => 11176852 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/176852
Method for treatment of cancer Jul 6, 2005 Abandoned
Array ( [id] => 5638102 [patent_doc_number] => 20060069076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'LXR/RXR-related methods and compositions' [patent_app_type] => utility [patent_app_number] => 11/172317 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6514 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069076.pdf [firstpage_image] =>[orig_patent_app_number] => 11172317 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/172317
LXR/RXR-related methods and compositions Jun 28, 2005 Abandoned
Array ( [id] => 7233850 [patent_doc_number] => 20050256134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders' [patent_app_type] => utility [patent_app_number] => 11/159590 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9201 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256134.pdf [firstpage_image] =>[orig_patent_app_number] => 11159590 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/159590
Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders Jun 21, 2005 Abandoned
Array ( [id] => 5801413 [patent_doc_number] => 20060035881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Use of targeted oxidative therapeutic formulation in endodontic treatment' [patent_app_type] => utility [patent_app_number] => 11/158514 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6587 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035881.pdf [firstpage_image] =>[orig_patent_app_number] => 11158514 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/158514
Use of targeted oxidative therapeutic formulation in endodontic treatment Jun 21, 2005 Abandoned
Array ( [id] => 4451263 [patent_doc_number] => 07964587 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Tocopherol and tocotrienol aerosols' [patent_app_type] => utility [patent_app_number] => 11/159917 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8189 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964587.pdf [firstpage_image] =>[orig_patent_app_number] => 11159917 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/159917
Tocopherol and tocotrienol aerosols Jun 21, 2005 Issued
Array ( [id] => 4676975 [patent_doc_number] => 20080214606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells' [patent_app_type] => utility [patent_app_number] => 11/629233 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27686 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214606.pdf [firstpage_image] =>[orig_patent_app_number] => 11629233 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/629233
Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells Jun 15, 2005 Abandoned
Array ( [id] => 7250639 [patent_doc_number] => 20050272738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Combined treatment with oxaliplatin and an epidermal growth factor receptor kinase inhibitor' [patent_app_type] => utility [patent_app_number] => 11/145091 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13750 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272738.pdf [firstpage_image] =>[orig_patent_app_number] => 11145091 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/145091
Combined treatment with oxaliplatin and an epidermal growth factor receptor kinase inhibitor Jun 2, 2005 Abandoned
Array ( [id] => 7250635 [patent_doc_number] => 20050272737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Combined treatment with irinotecan and an epidermal growth factor receptor kinase inhibitor' [patent_app_type] => utility [patent_app_number] => 11/144855 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15353 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272737.pdf [firstpage_image] =>[orig_patent_app_number] => 11144855 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/144855
Combined treatment with irinotecan and an epidermal growth factor receptor kinase inhibitor Jun 2, 2005 Abandoned
Array ( [id] => 7250346 [patent_doc_number] => 20050272688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Combined treatment with gemcitabine and an epidermal growth factor receptor kinase inhibitor' [patent_app_type] => utility [patent_app_number] => 11/144952 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14751 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272688.pdf [firstpage_image] =>[orig_patent_app_number] => 11144952 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/144952
Combined treatment with gemcitabine and an epidermal growth factor receptor kinase inhibitor Jun 2, 2005 Abandoned
Array ( [id] => 5397320 [patent_doc_number] => 20090317383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'CANCER TREATMENT METHOD' [patent_app_type] => utility [patent_app_number] => 11/569878 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8360 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317383.pdf [firstpage_image] =>[orig_patent_app_number] => 11569878 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/569878
CANCER TREATMENT METHOD Jun 2, 2005 Abandoned
Array ( [id] => 6931808 [patent_doc_number] => 20050282843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Therapeutic applications of 2-substituted 4-heteroarylpyrimidines' [patent_app_type] => utility [patent_app_number] => 11/140136 [patent_app_country] => US [patent_app_date] => 2005-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16310 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282843.pdf [firstpage_image] =>[orig_patent_app_number] => 11140136 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/140136
Therapeutic applications of 2-substituted 4-heteroarylpyrimidines May 25, 2005 Abandoned
Menu